Elo Mutual Pension Insurance’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.29M | Sell |
23,529
-50
| -0.2% | -$2.75K | 0.03% | 391 |
|
2025
Q1 | $1.67M | Buy |
23,579
+4,510
| +24% | +$319K | 0.04% | 342 |
|
2024
Q4 | $1.25M | Buy |
19,069
+2,203
| +13% | +$145K | 0.03% | 427 |
|
2024
Q3 | $1.19M | Sell |
16,866
-17
| -0.1% | -$1.2K | 0.03% | 410 |
|
2024
Q2 | $1.39M | Sell |
16,883
-236
| -1% | -$19.4K | 0.03% | 360 |
|
2024
Q1 | $1.5M | Buy |
17,119
+690
| +4% | +$60.3K | 0.04% | 356 |
|
2023
Q4 | $1.58M | Buy |
16,429
+719
| +5% | +$69.3K | 0.04% | 332 |
|
2023
Q3 | $1.39M | Buy |
15,710
+624
| +4% | +$55.2K | 0.04% | 321 |
|
2023
Q2 | $1.31M | Buy |
15,086
+3,338
| +28% | +$289K | 0.04% | 342 |
|
2023
Q1 | $1.14M | Sell |
11,748
-2,570
| -18% | -$250K | 0.04% | 339 |
|
2022
Q4 | $1.48M | Buy |
14,318
+424
| +3% | +$43.9K | 0.05% | 303 |
|
2022
Q3 | $1.18M | Sell |
13,894
-612
| -4% | -$51.9K | 0.04% | 315 |
|
2022
Q2 | $1.2M | Buy |
14,506
+67
| +0.5% | +$5.55K | 0.04% | 329 |
|
2022
Q1 | $1.11M | Buy |
14,439
+561
| +4% | +$43.2K | 0.03% | 411 |
|
2021
Q4 | $1.23M | Buy |
13,878
+992
| +8% | +$87.6K | 0.03% | 360 |
|
2021
Q3 | $996K | Hold |
12,886
| – | – | 0.03% | 347 |
|
2021
Q2 | $1.08M | Sell |
12,886
-211
| -2% | -$17.6K | 0.04% | 345 |
|
2021
Q1 | $989K | Buy |
13,097
+203
| +2% | +$15.3K | 0.03% | 351 |
|
2020
Q4 | $1.13M | Buy |
+12,894
| New | +$1.13M | 0.04% | 316 |
|